Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan B Rountree

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Developmental Biology|February 28, 2003
Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genesStephen H Settle, Ryan B Rountree, Abhishek Sinha, et al.
Plos Biology|October 20, 2004
BMP receptor signaling is required for postnatal maintenance of articular cartilageRyan B Rountree, Michael Schoor, Hao Chen, et al.
Annals of the New York Academy of Sciences|December 18, 2007
Synovial joint formation during mouse limb skeletogenesis: roles of Indian hedgehog signalingEiki Koyama, Takanaga Ochiai, Ryan B Rountree, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2006
Mineral formation in joints caused by complete or joint-specific loss of ANK functionKyle A Gurley, Hao Chen, Catherine Guenther, et al.
The Journal of Investigative Dermatology|July 24, 2009
RIP4 regulates epidermal differentiation and cutaneous inflammationRyan B Rountree, Cynthia R Willis, Huyen Dinh, et al.
Journal for Immunotherapy of Cancer|October 21, 2014
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapyStefanie J Mandl, Ryan B Rountree, Tracy B Dela Cruz, et al.
Cancer Immunology, Immunotherapy : CII|August 9, 2011
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cellsStefanie J Mandl, Ryan B Rountree, Katie Dalpozzo, et al.
Plos One|February 25, 2016
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in MiceSusan P Foy, Barbara Sennino, Tracy dela Cruz, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2016
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cellsSusan P Foy, Stefanie J Mandl, Tracy dela Cruz, et al.
Cancer Research|June 15, 2011
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacyRyan B Rountree, Stefanie J Mandl, James M Nachtwey, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Developmental Biology|February 28, 2003
Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genesStephen H Settle, Ryan B Rountree, Abhishek Sinha, et al.
Plos Biology|October 20, 2004
BMP receptor signaling is required for postnatal maintenance of articular cartilageRyan B Rountree, Michael Schoor, Hao Chen, et al.
Annals of the New York Academy of Sciences|December 18, 2007
Synovial joint formation during mouse limb skeletogenesis: roles of Indian hedgehog signalingEiki Koyama, Takanaga Ochiai, Ryan B Rountree, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2006
Mineral formation in joints caused by complete or joint-specific loss of ANK functionKyle A Gurley, Hao Chen, Catherine Guenther, et al.
The Journal of Investigative Dermatology|July 24, 2009
RIP4 regulates epidermal differentiation and cutaneous inflammationRyan B Rountree, Cynthia R Willis, Huyen Dinh, et al.
Journal for Immunotherapy of Cancer|October 21, 2014
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapyStefanie J Mandl, Ryan B Rountree, Tracy B Dela Cruz, et al.
Cancer Immunology, Immunotherapy : CII|August 9, 2011
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cellsStefanie J Mandl, Ryan B Rountree, Katie Dalpozzo, et al.
Plos One|February 25, 2016
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in MiceSusan P Foy, Barbara Sennino, Tracy dela Cruz, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2016
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cellsSusan P Foy, Stefanie J Mandl, Tracy dela Cruz, et al.
Cancer Research|June 15, 2011
Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacyRyan B Rountree, Stefanie J Mandl, James M Nachtwey, et al.
Pageof 2